Low-dose interleukin-2 in patients with mild to moderate Alzheimer’s disease: a randomized clinical trial

Authors

Institutions

Publication Details

Journal
Alzheimer s Research & Therapy
Published
2025-07-04
DOI
https://doi.org/10.1186/s13195-025-01791-x
Citations
5
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
4.21

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Low-dose interleukin-2 in patients with mild to moderate Alzheimer’s disease: a randomized clinical trial

Michael Grundman, Stanley H. Appel, Michael George, Belén Pascual et al.
5 citations
Alzheimer s Research & Therapy
Neuroinflammation and Neurodegeneration Mechanisms
4.21
article

Low-dose interleukin-2 in patients with mild to moderate Alzheimer’s disease: a randomized clinical trial

Michael Grundman, Stanley H. Appel, Michael George, Belén Pascual, Joseph C. Masdeu, Jason R. Thonhoff, David R. Beers, Daling Li, Aaron D. Thome, Jon B. Toledo, Alireza Faridar, Nazaret Gamez, Mohammad Obadah Nakawah, Weihua Zhao, Gustavo C. Román, John Volpi, Charles S. Davis, Yanling Wang, Reena Boradia
article en
5 citations

Abstract

No abstract available for this paper.
Alzheimer s Research & TherapyVol. 17(1)
Houston Methodist (US), University of San Diego (US), Neurosciences Institute (US), University of California San Diego (US), Partners In Care (US), Methodist Hospital (US), Community Science and Data Center (US)
Alzheimer's Association, National Institutes of Health, Houston Methodist Research Institute
Good health and well-being
Openalex Percentile: Top 6%
Neuroinflammation and Neurodegeneration Mechanisms
4.21
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Low-dose interleukin-2 in patients with mild to moderate Alzheimer’s disease: a randomized clinical trial — Michael Grundman, Stanley H. Appel, et al. · Alzheimer s Research & Therapy (2025) | TGRS Research Map | TGRS